Collegium Announces Updates to its Board of Directors and Executive Leadership Team
Gino Santini Appointed as Chairman of the Board, Michael Heffernan, Founder and Chairman and Gwen A. Melincoff, Board Member to Retire ...
Collegium制药重组董事会并扩充高管团队，市值达9.28亿美元
总部位于马萨诸塞州斯托顿的Collegium Pharmaceutical, Inc.（纳斯达克代码：COLL）是一家多元化生物制药公司，市值达9.28亿美元，毛利率高达87%。该公司今日宣布对其董事会和高管团队进行重大调整。根据 InvestingPro 分析，公司的财务健康状况评级为"优秀"，为未来增长奠定了良好基础。Gino Santini将接替公司创始人Michael ...